Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating Medrol Dose Pack for treating headaches after concussions

Official title: Assessment of the Efficacy of Medrol Dose Pack for Post-Concussive Headaches

Run by Northwell Health · NCT04685772 · Data updated 2026-11-12

This study is testing if a medication called Medrol can help people with headaches after a concussion feel better and get back to their normal activities faster.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorNorthwell Health
Academic / other
Locations1 site (Manhasset, New York)
StatusRecruiting
StartedApril 1, 2021
Main results expectedDecember 1, 2027
Study endsDecember 1, 2027
Registry record updatedAugust 26, 2026
Trial IDNCT04685772 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who experience daily headaches of significant severity following a concussion.

Probably not a fit

Patients with known intracranial hemorrhage or those whose headaches do not meet the study criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effectiveness of corticosteroids, specifically the Medrol Dose Pack, in reducing the frequency and intensity of acute post-concussive headaches. The investigators hypothesize that corticosteroid treatment will not only alleviate headaches but also decrease other related symptoms, facilitating a quicker return to normal activities such as school, work, or sports. The study is novel as it focuses on individuals suffering from post-concussion headaches, a condition that currently lacks established treatment guidelines. Participants will be monitored for their response to the medication over a specified period.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option for patients suffering from debilitating post-concussive headaches.

How similar studies have gone: While corticosteroids have been studied in severe traumatic brain injury, this specific approach for post-concussive headaches is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provision of signed and dated informed consent form (in person or via telehealth)
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Male or female, aged \>18 years old
4. Ability to take oral medication and be willing to adhere to the study regimen as described in this protocol
5. Patients presenting with all types of post-concussive headache with \>5/10 in severity on the numerical analog scale.
6. Headache that occurs for \> 4 hours per day
7. Headache that occurs every day
8. Headache that began after concussion, patient was diagnosed at an outpatient clinic or was hospitalized
9. Headache developed within 7 days post-injury and patient presenting within 30 days from initial trauma
10. A diagnosis of concussion.
11. If a patient is taking another pain medication, this still be included in the stud

Exclusion Criteria:

1. Any evidence of known intracranial hemorrhage on neuroimaging
2. Headache developing after 7 days post injury and patient presenting after 30 days from initial trauma
3. Headache occurs \< 4 hours per day
4. Headache does not occur daily
5. Age \< or = 18
6. Headache is \< 5 in severity on numerical analog scale
7. Presence of increase in intracranial pressure or papilledema
8. Any contraindication to corticosteroids
9. Allergy or sensitivity to corticosteroids
10. Active Tuberculosis
11. Active pregnancy
12. Currently on corticosteroids for another reason
13. Participants with fungal infection

Where it's running

  • Northwell Health - North Shore University Hospital
    Manhasset, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.